Guest guest Posted April 17, 2004 Report Share Posted April 17, 2004 Note the date: I understand testing has become more powerful since then, Beach. Adrienne Lyme and CFS Because several people have mentioned Lyme and CFS in the same breath, I thought that I would mention the following: According to a medical paper published by Dr. Bell, titled " Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases " by Bell KM, Cookfair D, Bell DS, Reese P, L and published in Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S32-8, Dr. Bell tested all his patients for Lyme and they all tested negative! FYI, Beach This list is intended for patients to share personal experiences with each other, not to give medical advice. If you are interested in any treatment discussed here, please consult your doctor. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 17, 2004 Report Share Posted April 17, 2004 > Because several people have mentioned Lyme and CFS in the same > breath, I thought that I would mention the following: > According to a medical paper published by Dr. Bell, titled " Risk > factors associated with chronic fatigue syndrome in a cluster of > pediatric cases " by Bell KM, Cookfair D, Bell DS, Reese P, L and > published in Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S32-8, > Dr. Bell tested all his patients for Lyme and they all tested negative! > > FYI, > Beach This means absolutely nothing, it depends what tests were used, most are useless in late onset Lymes disease. Pam Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 17, 2004 Report Share Posted April 17, 2004 I don't think that would be significant at all. I would like to know the testing methods though--like did they use the highly innaccurate ELISA just like my ignorant CFS doc did in VA when I first went to him with a request to test me for lyme, skipping the WB test alltogether (it's amazing b/c when I went to Labcorp office after finally seeing a LLMD they were surprised I was getting WB's w/o and thought WB is done only after getting a pos on ELISA, yet any lyme literate person knows ELISA is practically worthless except for if one has very recent tick bite exposure)? Even people I know who were bit by ticks and got lyme showed up neg for CDC standards using Labcorp western blots, so taken back in 1991 I'd say it would be virtually irrelevant that Bell found it in none of his patients. In fact, even a lyme skeptic should realize that there are always going to be crossovers and misdiagnosis and folks who got lyme from a tick bite but never recognized it and walked around thinking they are CFS, so the fact that none of his patients showed up as lyme when at least a few should have just based on misdiagnosis ought to suggest the high inaccuracies of testing. FWIW. In a message dated 4/17/2004 2:58:10 AM Eastern Daylight Time, writes: Because several people have mentioned Lyme and CFS in the same breath, I thought that I would mention the following: According to a medical paper published by Dr. Bell, titled " Risk factors associated with chronic fatigue syndrome in a cluster of pediatric cases " by Bell KM, Cookfair D, Bell DS, Reese P, L and published in Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S32-8, Dr. Bell tested all his patients for Lyme and they all tested negative! Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 17, 2004 Report Share Posted April 17, 2004 Yes, technology has changed over the years regarding testing....it always does.....but read on: Lyme disease is the most prevalent vector-borne disease of humans in the United States and is transmitted by the bite of Ixodes ticks. Infection is caused by the bacterium Borrelia burgdorferi resulting in an illness affecting various organ systems of the body. The clinical implications of Lyme disease can be seen in dermatologic, neurologic and rheumatologic manifestations. No matter what causes the manifestation of Lyme disease, the key to avoiding serious effects is prompt diagnosis and treatment of the underlying disorder. Unfortunately, making a definitive diagnosis of Lyme disease during the early stages can be difficult, especially when the characteristic rash is not evident. Other symptoms, such as flu-like complaints, which can be caused by many other factors, are added to the severity of the problem. Moreover, available blood tests for diagnosing Lyme disease detect antibodies that, in most cases, do not appear in the blood until several weeks or months after the onset of infection. This property makes the current laboratory diagnosis of antibody detection unreliable. The diagnostic value of antibody assays is unsatisfactory in early disease due to low sensitivity, serological cross-reactions and the inability to distinguish between active and inactive infection due to antibody persistence after therapy. The pathogen can also be detected by culture; however, the sensitivity of this technique is low, ranging from 30 to 70% for culture of skin biopsy specimens to less than 5% for culture of cerebrospinal fluid. This lack of sensitivity of culture methods is due to the low number of organisms in clinical specimens. Due to poor sensitivity and specificity of serological tests for Lyme Borreliosis, and since clinicians tend to rely upon these tests as the primary indication of infection, laboratories are required to participate in a proficiency-testing program. In fact, based on these proficiency tests, 55% of laboratories participating in the Wisconsin Blind Testing Program could not accurately identify serum samples from Lyme disease patients containing antibodies against Borrelia burgdorferi. In addition, up to 27% of laboratories identified as positive serum samples from individuals with no known exposure to B. burgdorferi. This false positivity in the antibody reaction is related to the cross-reactive spirochetes, to which healthy controls may have been exposed before. To overcome problems related to the presence or the absence of antibodies during the active or chronic phase of the infection and to solve specificity, sensitivity and false positivity of Lyme disease diagnosis, one should apply DNA technology. Detection of B. burgdorferi-specific DNA fingerprint in the body fluid indicates the presence of the whole organism, since spirochete DNA would be unlikely to persist very long after the spirochete that carried it had perished. PCR for the diagnosis of infectious diseases has been directed primarily toward the detection of organisms for which conventional diagnostic techniques either lack sensitivity or specificity. Unlike other bacterial and viral disease, the number of organisms in clinical specimens in Lyme disease is extremely low. Although there can be up to 4,500 spirochetes per infected tick, the number of genomes in the urine or blood of infected patients is generally less than 50 per ml and rarely exceeds 5,000/ml. By utilizing PCR, a targeted sequence of DNA may be amplified at an exponential rate providing a detection capability unmatched by any other diagnostic procedure. The ability to detect one copy of a specific sequence of Borrelia burgdorferi has made PCR methods attractive in the laboratory diagnosis of Lyme borreliosis. The advantages of PCR over other methodologies are its speed, its high degree of sensitivity and specificity, and its cost-effectiveness. FYI, Beach > Because several people have mentioned Lyme and CFS in the same > breath, I thought that I would mention the following: > According to a medical paper published by Dr. Bell, titled " Risk > factors associated with chronic fatigue syndrome in a cluster of > pediatric cases " by Bell KM, Cookfair D, Bell DS, Reese P, L and > published in Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S32-8, > Dr. Bell tested all his patients for Lyme and they all tested negative! > > FYI, > Beach Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 17, 2004 Report Share Posted April 17, 2004 Here's the current CDC view of Lyme, from their website: From the CDC website: Diagnosis: The diagnosis of Lyme disease is based primarily on clinical findings, and it is often appropriate to treat patients with early disease solely on the basis of objective signs and a known exposure. Serologic testing may, however, provide valuable supportive diagnostic information in patients with endemic exposure and objective clinical findings that suggest later stage disseminated Lyme disease. When serologic testing is indicated, CDC recommends testing initially with a sensitive first test, either an enzyme-linked immunosorbent assay (ELISA) or an indirect fluorescent antibody (IFA) test, followed by testing with the more specific Western immunoblot (WB) test to corroborate equivocal or positive results obtained with the first test. Although antibiotic treatment in early localized disease may blunt or abrogate the antibody response, patients with early disseminated or late-stage disease usually have strong serological reactivity and demonstrate expanded WB immunoglobulin G (IgG) banding patterns to diagnostic B. burgdorferi antigens. Antibodies often persist for months or years following successfully treated or untreated infection. Thus, seroreactivity alone cannot be used as a marker of active disease. Neither positive serologic test results nor a history of previous Lyme disease assures that an individual has protective immunity. Repeated infection with B. burgdorferi has been documented. B. burgdorferi can be cultured from 80% or more of biopsy specimens taken from early erythema migrans lesions. However, the diagnostic usefulness of this procedure is limited because of the need for a special bacteriologic medium (modified Barbour-Stoenner- medium) and protracted observation of cultures. Polymerase chain reaction (PCR) has been used to amplify genomic DNA of B. burgdorferi in skin, blood, cerobro-spinal fluid, and synovial fluid, but PCR has not been standardized for routine diagnosis of Lyme disease. FYI, Beach > Because several people have mentioned Lyme and CFS in the same > breath, I thought that I would mention the following: > According to a medical paper published by Dr. Bell, titled " Risk > factors associated with chronic fatigue syndrome in a cluster of > pediatric cases " by Bell KM, Cookfair D, Bell DS, Reese P, L and > published in Rev Infect Dis. 1991 Jan-Feb;13 Suppl 1:S32-8, > Dr. Bell tested all his patients for Lyme and they all tested negative! > > FYI, > Beach Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.